You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


DSRU says more research needed to understand immunocompromised patients’ responses to COVID-19 vaccines

The UK’s independent Drug Safety Research Unit (DSRU) has called for more research to understand the weaker COVID-19 vaccine protection for immunocompromised patients.